Gennex Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
For the six months, sales was INR 330.5 million compared to INR 245.31 million a year ago. Revenue was INR 341.34 million compared to INR 246.91 million a year ago. Net income was INR 18 million compared to INR 20.6 million a year ago. Basic earnings per share from continuing operations was INR 0.142 compared to INR 0.163 a year ago. Diluted earnings per share from continuing operations was INR 0.142 compared to INR 0.163 a year ago.